Clinical Trial Report

Current Cardiology Reports

, 13:357

First online:

Review of the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial: Warfarin Versus Dabigatran

  • Christopher IngelmoAffiliated withDirector of Cardiac EP OPD, Director Research Development, Cleveland Clinic Foundation
  • , Oussama WazniAffiliated withDirector of Cardiac EP OPD, Director Research Development, Cleveland Clinic Foundation Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Keywords

Atrial fibrillation Warfarin Dabigatran RE-LY trial Anticoagulation therapy